Holdings
DAFNA Capital Management LLC
As of Sep 30, 2026, DAFNA Capital Management LLC reported 77 positions worth US$446M. Largest: Revolution Medicines, Inc., AtriCure, Inc. and COMPASS Pathways Plc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Revolution Medicines, Inc. | 487K | US$100M | −75,500 | Sep 30, 2026 |
| AtriCure, Inc. | 523K | US$29.4M | −74,684 | Sep 30, 2026 |
| COMPASS Pathways Plc | 2.14M | US$26.6M | new | Sep 30, 2026 |
| State Street SPDR S&P Biotech ETF | 152K | US$23.9M | new | Sep 30, 2026 |
| Nektar Therapeutics | 323K | US$19.6M | +5,000 | Sep 30, 2026 |
| IDEAYA Biosciences, Inc. | 439K | US$16.9M | −58,500 | Sep 30, 2026 |
| Stereotaxis, Inc. | 13.7M | US$16.8M | no change | Sep 30, 2026 |
| Denali Therapeutics Inc. | 744K | US$15.4M | +5,000 | Sep 30, 2026 |
| Arcus Biosciences, Inc. | 440K | US$11.4M | −2,000 | Sep 30, 2026 |
| Cytokinetics, Incorporated | 172K | US$11.3M | no change | Sep 30, 2026 |